Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Update: 2025-10-01
Description
Guest: Alexis Leonard
With two FDA-approved gene therapies, including the first CRISPR-based treatment, curative strategies for sickle cell disease are continuing to expand the treatment landscape. However, challenges remain in optimizing safety and accessibility, particularly for patients unable to tolerate current myeloablative conditioning. Learn about advancements in ex vivo editing, such as improved stem cell targeting and multiplex editing, and the possibility of in vivo approaches that may help transform sickle cell disease management with Dr. Alexis Leonard, who works in the Department of Hematology at St. Jude’s Hospital in Memphis, Tennessee.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
